Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

Manufacturer
LUPIN LIMITED
Effective date
2016-02-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:29:15

Label at a glance#

ProductFallback Solo
Active ingredientLEVONORGESTREL
Label structure13 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Fallback Solo™

(levonorgestrel) Tablet, 1.5 mg

Drug Facts

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Levonorgestrel USP 1.5 mg

Purpose

OTC - PURPOSE SECTION

Emergency contraceptive

Indications

INDICATIONS & USAGE SECTION

Use for women 17 years of age and older to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control).

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you have ever had an allergic reaction to levonorgestrel.

Sexually transmitted diseases (STDs) alert: This product does not protect against HIV/AIDS or other STDs

Do not use

  • if you are already pregnant (because it will not work)
  • for regular birth control

When using this product you may have

  • menstrual changes
  • nausea
  • lower stomach (abdominal) pain
  • tiredness
  • headache
  • dizziness
  • breast pain
  • vomiting

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

This package is not child resistant. Keep this and all medication out of the reach of children.

In case of overdose, get medical help or contact a Poison Control center right away.

SPL UNCLASSIFIED SECTION

Directions

■      women 17 years of age and older:

  • take tablet as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.
  • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose.

Other Information

  • read the instructions, warnings and enclosed product leaflet before use .
  • this product works mainly by preventing ovulation (egg release). It may also prevent fertilization of a released egg (joining of sperm and egg) or attachment of a fertilized egg to the uterus (implantation).
  • tablet is enclosed in wallet seal. Do not use if the wallet seal is broken .
  • store at 25°C (77°C); excursions permitted to 15 to 30°C (59 to 86°C) [see USP Controlled Room temperature].

Inactive Ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and povidone.

SPL UNCLASSIFIED SECTION

Questions or comments?

For more information call 1800-399-2561 or visit our website at www.birthcontrolhealth.com.

SPL UNCLASSIFIED SECTION

Fallback Solo™

(levonorgestrel) Tablet, 1.5 mg

Emergency Contraceptive

One Tablet. One Dose.

SPL UNCLASSIFIED SECTION

What You Need to Know

What is Fallback Solo™?

Fallback Solo™ is emergency contraception that helps prevent pregnancy after birth control failure or unprotected sex. It is a backup method of preventing pregnancy and should not be used as regular birth control.

What Fallback Solo is not.

Fallback Solo will not work if you are already pregnant and will not affect an existing pregnancy. Fallback Solo will not protect you from HIV infection (the virus that causes AIDS) and other sexually transmitted diseases (STDs).

When should I use Fallback Solo?

DOSAGE & ADMINISTRATION SECTION

The sooner you take emergency contraception, the better it works. You should use Fallback Solo within 72 hours (3 days) after you have had unprotected sex.

Fallback Solo is a backup or emergency method of birth control you can use when:

  • your regular birth control was used incorrectly or failed
  • you did not use any birth control method

SPL UNCLASSIFIED SECTION

When not to use Fallback Solo?

Fallback Solo should not be used:

  • as a regular birth control method, because it's not as effective as regular birth control.
  • if you are already pregnant, because it will not work.
  • if you are allergic to levonorgestrel or any other ingredients in Fallback Solo.

How does Fallback Solo work?

Fallback Solo is one tablet with levonorgestrel, a hormone that has been used in many birth control pills for several decades. Fallback Solo contains a higher dose of levonorgestrel than birth control pills, but works in a similar way to prevent pregnancy. It works mainly by stopping the release of an egg from the ovary. It is possible that Fallback Solo may also work by preventing fertilization of an egg (the uniting of sperm with the egg) or by preventing attachment (implantation) to the uterus (womb).

How can I get the best results from Fallback Solo?

You have 72 hours (3 days) to try to prevent pregnancy after birth control failure or unprotected sex. The sooner you take Fallback Solo, the better it works.

How effective is Fallback Solo?

If Fallback Solo is taken as directed, it can significantly decrease the chance that you will get pregnant. About 7 out of every 8 women who would have gotten pregnant will not become pregnant.

How will I know Fallback Solo worked?

You will know Fallback Solo has been effective when you get your next period, which should come at the expected time, or within a week of the expected time. If your period is delayed beyond 1 week, it is possible you may be pregnant. You should get a pregnancy test and follow up with your healthcare professional.

Will I experience any side effects?

  •   some women may have changes in their period, such as a period that is heavier or lighter or a period that is early or late. If your period is more than a week late, you may be pregnant.
  •   If you have severe abdominal pain, you may have an ectopic pregnancy, and should get immediate medical attention.
  •   when used as directed, Fallback Solo is safe and effective. Side effects may include changes in your period, nausea, lower stomach (abdominal) pain, tiredness, headache, dizziness, and breast tenderness.
  •   if you vomit within 2 hours of taking the medication, call a healthcare professional to find out if you should repeat the dose.

What if I still have questions about Fallback Solo?

If you have questions or need more information, call our toll-free number, 1800-399-2561 or visit our website at www.birthcontrolhealth.com.

Other Information

Keep this and all medication out of reach of children:

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Do not use if the wallet seal is opened.

Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F). [see USP Controlled Room Temperature].

Active Ingredient: levonorgestrel 1.5 mg

Inactive Ingredients: colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and povidone.

Fallback Solo™ is a trademark of Lupin Pharmaceuticals, Inc.

Distributed By:

Lupin Pharmaceuticals, Inc.

Baltimore, Maryland 21202

United States

Manufactured by:

Lupin Limited

Pithampur (M.P.) - 454 775

INDIA

June 2014                                                                                            ID#: 231975

If you are sexually active, you should see a healthcare provider for routine checkups. Your healthcare provider will talk to you about and, if necessary, test you for sexually transmitted diseases, teach you about effective methods of routine birth control, and answer any other questions you may have.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

NDC 68180-853-11

Wallet Label: 1 Tablet

Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-11 Wallet Label: 1 Tablet
Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-11 Wallet Label: 1 Tablet

Fallback Solo™ (levonorgestrel) Tablet, 1.5 mg

NDC 68180-853-13

Carton Label: 1 Tablet

Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-13 Carton Label: 1 Tablet
Fallback Solo (levonorgestrel) Tablet, 1.5 mg NDC 68180-853-13 Carton Label: 1 Tablet

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57297-85357297-853-11, 57297-853-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A201446-001FALLBACK SOLOLEVONORGESTREL1.5MGTABLET / ORAL2014-06-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1984e616aacf4f…
2026-08-18 06:07:402026-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-1987673890dc5c…
2021-03-12 10:30 UTC2021-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193f01610625f2…
2019-09-15 20:21 UTC2019-09A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19b00525d2431f…
2019-07-19 19:46 UTC2019-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193f0d92c62455…
2023-05-13 08:27 UTC2023-05A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19053a50430f4f…
2023-01-26 05:58 UTC2023-01A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-193a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A201446-001FALLBACK SOLO1.5MGTABLET / ORAL2014-06-19f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
93700184-140c-43c0-86e4-596425bc53d9b2d5d0c2-f10a-4c39-af03-17a87fc4bd9d2024-12-06WarningsExact identifier
spl set id: b2d5d0c2-f10a-4c39-af03-17a87fc4bd9d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.